**Executive Summary**
This document, dated December 5, 2025, from the Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, provides an overview of governmental efforts to promote the medical device industry in India. It outlines key initiatives, including the Production Linked Incentive (PLI) scheme, the Scheme for Promotion of Medical Devices Parks, and the Scheme for Strengthening Medical Device Industry. The document also includes an annexure with state-wise details of licensed medical device manufacturing sites from 2021 to 2025, in response to Lok Sabha Unstarred Question No. 964.
**Key Points / Main Content**
* **Government Initiatives to Promote the Medical Device Industry:**
* **Production Linked Incentive (PLI) Scheme:**
* Budgetary outlay of ₹3,420 crore with a five-year performance-linked incentive period (FY2022-23 to FY2026-27).
* Provides financial incentives to selected companies for incremental sales of domestically manufactured medical devices in specific segments.
* As of September 2025, 22 greenfield projects have been commissioned, with production started for 55 products.
* Cumulative eligible sales of ₹12,344.37 crore have been made, including export sales worth ₹5,869.36 crore, till September 2025.
* **Scheme for Promotion of Medical Devices Parks:**
* Aims to provide access to world-class common infrastructure facilities in medical device parks.
* Three parks approved in Greater Noida, Ujjain, and Kanchipuram.
* Total project cost of ₹871.11 crore, with Central assistance of ₹100 crore each.
* As of November 2025, ₹180 crore out of ₹300 crore has been released.
* As of September 2025, 194 manufacturers have been allotted land and 34 units have started construction.
* **Scheme for Strengthening Medical Device Industry:**
* Launched on November 8, 2024, with a financial outlay of ₹500 crore.
* Aims to strengthen the industry by supporting critical areas such as manufacturing of key components, skill development, and infrastructure.
* Includes sub-schemes like:
* Common Facilities for Medical Devices Clusters.
* Marginal Investment Scheme for Reducing Import Dependence.
* Capacity Building and Skill Development for Medical Devices.
* Medical Device Clinical Studies Support Scheme.
* Medical Device Promotion Scheme.
* **Annexure Details:**
* Provides state-wise details of medical device manufacturing sites licensed between 2021 and 2025.
* Lists the number of manufacturing sites licensed for each state/union territory.
**Impact Analysis**
**Medical Device Manufacturers**
* **Impact:** Access to financial incentives, improved infrastructure, and support for skill development and research. Allotment of land in medical device parks.
* **Action Required:** Evaluate eligibility for PLI scheme benefits, explore opportunities in medical device parks, and leverage support for capacity building and clinical studies.
**State Governments**
* **Impact:** Increased medical device manufacturing activity within their jurisdictions, potential for economic growth, and improved healthcare infrastructure.
* **Action Required:** Support the establishment and operation of medical device parks and facilitate the licensing of manufacturing sites.
**Healthcare Sector**
* **Impact:** Improved access to domestically manufactured medical devices, reduced import dependence, and potentially lower costs.
* **Action Required:** Monitor the availability of domestically produced medical devices and promote their adoption.
Key Entities Referenced
Production Linked Incentive (PLI) scheme for promoting domestic manufacturing of Medical Devices: Scheme with a budgetary outlay of ₹3,420 crore and a five-year performance-linked incentive period from FY2022-23 to FY2026-27 to promote domestic manufacturing of medical devices.
Scheme for Promotion of Medical Devices Parks: Scheme aiming to provide easy access to world-class, common infrastructure facilities to medical device units set up in medical device parks.
Scheme for Strengthening Medical Device Industry: Scheme launched on 8.11.2024 with a financial outlay of ₹500 crore to strengthen the medical device industry by providing support in critical areas.
Ministry of Chemicals and Fertilizers: The ministry responsible for the Department of Pharmaceuticals, which provided the information on medical device industries.
Uttar Pradesh, Madhya Pradesh, Tamil Nadu: Locations of Medical Device Parks under the Scheme for Promotion of Medical Devices Parks.
Ministry of Chemicals and Fertilizers :
Department of Pharmaceuticals
Medical Devices Industries in the country
प्रव तथ: 05 DEC 2025 4:26PM by PIB Delhi
The number and State-wise details of medical device manufacturing sites licensed in the country,
including in the State of Maharashtra, during the last five years, are given in the Annex.
The Government has made wide-ranging efforts to promote the medical device industry in the country,
including through provision of financial assistance for the setting up of medical device industry. These
efforts include the following:
i. Production Linked Incentive (PLI) scheme for promoting domestic manufacturing of Medical
Devices: This scheme has a budgetary outlay of ₹3,420 crore and a five-year performance-linked
incentive period from FY2022-23 to FY2026-27. Under the scheme, selected companies are eligible
for financial incentive for incremental sales of domestically manufactured medical devices in the
radiotherapy, imaging device, anaesthesia, cardio-respiratory and critical care and implant device
segments, for a period of five years. As of September 2025, 22 greenfield projects have been
commissioned and production has started for 55 products, which include high-end medical devices
on which the country has been highly import-dependent, such as linear accelerators, machines for
MRI and CT scans and mammograms, C-arm X-ray machines, MRI coils and ultrasound machines.
Till September 2025, cumulative eligible sales of ₹12,344.37 crore have been made under the
scheme, including export sales worth ₹5,869.36 crore.
ii. Scheme for Promotion of Medical Devices Parks: The scheme aims to provide easy access to world-
class, common infrastructure facilities to medical device units set up in medical device parks. Under
this scheme, three parks have been approved and are at an advanced stage of development in
Greater Noida (Uttar Pradesh), Ujjain (Madhya Pradesh) and Kanchipuram (Tamil Nadu) districts.
The total project cost of these is ₹871.11 crore, with Central assistance to the tune of ₹100 crore
each for creation of common infrastructure facilities, which is expected to enhance industry’s
competitiveness and reduce production costs through optimisation of resources and economies of
scale. As of November 2025, out of a total of ₹300 crore for the three parks, a total of ₹180 crore
stood released. Civil construction for the three parks is at the final stages. As of September 2025,
194 medical devices manufacturers have been allotted land in the three parks in a 298.58 acre area
and 34 units have commenced construction of their plants.
iii. Scheme for Strengthening Medical Device Industry: This scheme has been launched on 8.11.2024
with a financial outlay of ₹500 crore. It aims to strengthen the medical device industry by providing
support in critical areas, including manufacturing of key components and accessories, skill
development, support for clinical studies, development of common infrastructure, and industry
promotion and consists of the following sub-schemes:
1. Common Facilities for Medical Devices Clusters;
2. Marginal Investment Scheme for Reducing Import Dependence;
3. Capacity Building and Skill Development for Medical Devices;4. Medical Device Clinical Studies Support Scheme; and
5. Medical Device Promotion Scheme.
This information was given by Union Minister of State in the Ministry of Chemicals and Fertilizers, Smt.
Anupriya Patel, in a written reply in Lok Sabha today.
******
Annexure
Annexure referred to in the reply to parts (a) and (d) of the LOK SABHA UNSTARRED Q. NO. 964
for answer on 5.12.2025, regarding Medical Devices Industries
Number and State-wise details of medical device manufacturing sites licensed in the country,
including in the State of Maharashtra, during the last five years
State / Union territory Number of manufacturing site licensed
during the period from 2021 to 2025
Andhra Pradesh 58
Assam 7
Bihar 39
Chhattisgarh 13
Dadra and Nagar Haveli and Daman and Diu 34
Delhi 291
Goa 18
Gujarat 738
Haryana 302
Himachal Pradesh 49
Jammu And Kashmir 12
Jharkhand 3Karnataka 262
Kerala 187
Madhya Pradesh 78
Maharashtra 721
Manipur 3
Orissa 38
Puducherry 18
Punjab 78
Rajasthan 118
Tamil Nadu 346
Telangana 194
Uttarakhand 60
Uttar Pradesh 346
West Bengal 62
*****
PC/GS/SG
(रलीज़ आईडी: 2199433) आगंतुक पटल : 479
इस वज्ञ को इन भाषाओ ंम पढ़: ही